PMC:7665480 / 20182-20523
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 434 | 313-325 | Chemical | denotes | beta-lactams | MESH:D047090 |
| 435 | 330-340 | Chemical | denotes | macrolides | MESH:D018942 |
| 436 | 103-123 | Disease | denotes | bacterial infections | MESH:D001424 |
| 437 | 261-276 | Disease | denotes | lymphocytopenia | MESH:D008231 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T42 | 261-276 | Phenotype | denotes | lymphocytopenia | http://purl.obolibrary.org/obo/HP_0001888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T216 | 0-277 | Sentence | denotes | Not least, we considered the administration of broad-spectrum antibiotic therapy to avoid superimposed bacterial infections that would have a detrimental effect on the prognosis due to immunosuppression and corticosteroids, and the reduction of defenses due to lymphocytopenia. |
| T217 | 278-341 | Sentence | denotes | We mainly opted for broad spectrum beta-lactams and macrolides. |